Alexion Pharmaceuticals, Inc. (ALXN)

Growth

Revenue 5Y17.82%
Revenue 3Y20.43%
EPS 5Y32.42%
EPS 3Y11.63%
Dividend 5Y-
Dividend 3Y-

Capital Efficiency

ROIC16.01%
ROE5.98%
ROA3.66%
ROTA4.37%

Capital Structure

Market Cap40.34B
EV39.44B
Cash3.43B
Current Ratio4.52
Debt/Equity0.33
Net Debt/EBITDA-0.83
Show More

Income Statement

Select a metric from the list below to chart it

Jul '96
Jul '01
Dec '07
Dec '12
Dec '17
Income Statement
Dec '12
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
TTM
Revenue
1,551.3
2,233.7
2,604.0
3,084.0
3,551.1
4,131.2
4,991.1
6,069.9
6,261.6
Revenue % Chg.
36.8%
44.0%
16.6%
18.4%
15.1%
16.3%
20.8%
21.6%
18.2%
Cost of Revenue
177.6
173.9
233.1
258.0
454.2
374.3
394.5
553.5
567.2
Cost of Revenue % Chg.
143.8%
-2.1%
34.1%
10.7%
76.0%
-17.6%
5.4%
40.3%
34.9%
Gross Profit
1,373.8
2,059.9
2,371.0
2,826.0
3,096.9
3,756.9
4,596.6
5,516.4
5,694.4
Gross Profit % Chg.
29.4%
49.9%
15.1%
19.2%
9.6%
21.3%
22.4%
20.0%
16.8%
Gross Profit Margin
88.6%
92.2%
91.0%
91.6%
87.2%
90.9%
92.1%
90.9%
90.9%
Gross Profit Margin % Chg.
-5.4%
4.1%
-1.3%
0.6%
-4.8%
4.3%
1.3%
-1.3%
-1.2%
R&D Expenses
317.1
513.8
709.5
757.0
878.4
730.4
886.0
1,002.9
1,091.1
R&D Expenses % Chg.
42.4%
62.0%
38.1%
6.7%
16.0%
-16.8%
21.3%
13.2%
22.5%
Selling, General, & Admin Expenses
489.7
630.2
862.6
954.0
1,094.4
1,111.8
1,261.1
1,399.9
1,422.9
Selling, General, & Admin Expenses % Chg.
27.3%
28.7%
36.9%
10.6%
14.7%
1.6%
13.4%
11.0%
9.5%
Other Expenses
0.4
-
116.6
322.0
320.1
320.1
309.6
253.7
233.2
Other Expenses % Chg.
-
-
-
176.2%
-0.6%
-
-3.3%
-18.1%
-23.1%
Operating Income
566.6
915.9
682.3
793.0
804.0
1,594.6
2,139.9
2,859.9
2,757.5
Operating Income % Chg.
24.9%
61.7%
-25.5%
16.2%
1.4%
98.3%
34.2%
33.6%
15.8%
Operating Income Margin
36.5%
41.0%
26.2%
25.7%
22.6%
38.6%
42.9%
47.1%
44.0%
Operating Income Margin % Chg.
-8.7%
12.3%
-36.1%
-1.9%
-11.9%
70.5%
11.1%
9.9%
-2.1%
Total Other Income/Expenses Net
-40.3
-43.8
-184.2
-217.0
-256.2
-1,352.4
38.9
-2,290.9
-2,249.5
Total Other Income/Expenses Net % Chg.
27.9%
8.6%
320.7%
17.8%
18.1%
427.9%
-
-
2687.5%
Income Before Tax
526.3
872.1
498.1
576.0
547.8
242.2
2,178.8
569.0
508.0
Income Before Tax % Chg.
32.4%
65.7%
-42.9%
15.6%
-4.9%
-55.8%
799.6%
-73.9%
-77.9%
Income Before Tax Margin
33.9%
39.0%
19.1%
18.7%
15.4%
5.9%
43.7%
9.4%
8.1%
Income Before Tax Margin % Chg.
-3.2%
15.1%
-51.0%
-2.4%
-17.4%
-62.0%
644.6%
-78.5%
-81.3%
Income Tax Expense
273.4
215.2
353.8
177.0
104.5
164.6
-225.5
-34.4
-27.0
Income Tax Expense % Chg.
91.5%
-21.3%
64.4%
-50.0%
-41.0%
57.5%
-
84.7%
63.2%
Net Income
252.9
656.9
144.4
399.0
443.3
77.6
2,404.3
603.4
681.8
Net Income % Chg.
-0.8%
159.8%
-78.0%
176.3%
11.1%
-82.5%
2998.3%
-74.9%
-71.3%
Net Income Margin
16.3%
29.4%
5.5%
12.9%
12.5%
1.9%
48.2%
9.9%
10.9%
Net Income Margin % Chg.
-27.4%
80.4%
-81.1%
133.3%
-3.5%
-85.0%
2464.5%
-79.4%
-75.7%
Weighted Avg. Shares Out
195.5
198.1
213.4
224.0
223.9
222.7
223.2
219.1
219.7
Weighted Avg. Shares Out % Chg.
2.7%
1.3%
7.7%
5.0%
-0.0%
-0.5%
0.2%
-1.8%
-1.3%
EPS
1.3
3.3
0.7
1.8
2.0
0.3
10.8
2.7
3.1
EPS % Chg.
-3.7%
157.4%
-79.5%
161.8%
11.2%
-82.4%
2990.8%
-74.6%
-70.6%
Weighted Avg. Shares Out Dil
199.7
201.6
215.9
227.0
225.4
224.5
224.8
219.1
220.7
Weighted Avg. Shares Out Dil % Chg.
0.6%
1.0%
7.1%
5.1%
-0.7%
-0.4%
0.1%
-2.5%
-1.4%
EPS Diluted
1.3
3.3
0.7
1.8
2.0
0.3
10.7
2.7
3.1
EPS Diluted % Chg.
-0.8%
156.7%
-79.4%
162.7%
11.9%
-82.5%
2995.6%
-74.6%
-70.9%
Interest Expense
4.1
3.0
47.7
97.0
98.4
98.2
77.8
104.7
106.0
Interest Expense % Chg.
-44.4%
-27.5%
1501.1%
103.2%
1.4%
-0.2%
-20.8%
34.6%
26.6%
EBIT
522.2
869.1
450.4
479.0
449.4
144.0
2,101.0
464.3
402.0
EBIT % Chg.
33.8%
66.4%
-48.2%
6.4%
-6.2%
-68.0%
1359.0%
-77.9%
-81.9%
EBIT Margin
33.7%
38.9%
17.3%
15.5%
12.7%
3.5%
42.1%
7.6%
6.4%
EBIT Margin % Chg.
-2.2%
15.6%
-55.5%
-10.2%
-18.5%
-72.5%
1107.7%
-81.8%
-84.7%
Depreciation & Amortization
28.7
46.9
166.6
396.0
496.7
405.3
376.8
329.4
315.7
Depreciation & Amortization % Chg.
20.1%
63.6%
255.0%
137.7%
25.4%
-18.4%
-7.0%
-12.6%
-14.4%
EBITDA
550.9
916.1
617.0
875.0
946.1
549.3
2,477.8
793.7
717.7
EBITDA % Chg.
33.0%
66.3%
-32.6%
41.8%
8.1%
-41.9%
351.1%
-68.0%
-72.2%
EBITDA Margin
35.5%
41.0%
23.7%
28.4%
26.6%
13.3%
49.6%
13.1%
11.5%
EBITDA Margin % Chg.
-2.7%
15.5%
-42.2%
19.7%
-6.1%
-50.1%
273.4%
-73.7%
-76.5%